project id: TCGA-ESCA; case submitter id: TCGA-R6-A8WC; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.8; rna integrity number: 9.9; age at index: 56; days to birth: -20812; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1957; age at diagnosis: 20812; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIA; ajcc clinical t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 70.0; icd 10 code: C15.5; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower third of esophagus; synchronous malignancy: No; tissue or organ of origin: Lower third of esophagus; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: not reported; alcohol history: Yes; cigarettes per day: 0.1643835616438356; pack years smoked: 3.0; is ffpe: false; weight: 5.0; composition: Not Reported; days to collection: 119; days to sample procurement: 0; sample id: e8e2d4f2-3d7e-432b-b1ea-d2823cbf9842; sample submitter id: TCGA-R6-A8WC-01A; portion id: 8672d9ac-a515-423a-ad54-c8dfe746167e; portion submitter id: TCGA-R6-A8WC-01A-11; slide id: d7838b62-73c9-4fc8-ac0a-28dab10470ba; slide submitter id: TCGA-R6-A8WC-01Z-00-DX1; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0; section location: TOP;